Gene: RAVER1
Official Full Name: ribonucleoprotein, PTB binding 1provided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27489 | RAVER1 Knockout cell line (HeLa) | Human | RAVER1 | 1:3~1:6 | Negative | Online Inquiry |
KO27490 | RAVER1 Knockout cell line (HCT 116) | Human | RAVER1 | 1:2~1:4 | Negative | Online Inquiry |
KO27491 | RAVER1 Knockout cell line (HEK293) | Human | RAVER1 | 1:3~1:6 | Negative | Online Inquiry |
KO27492 | RAVER1 Knockout cell line (A549) | Human | RAVER1 | 1:3~1:4 | Negative | Online Inquiry |
RAVER1 Gene Knockout Cell Lines are specialized, genetically modified cell lines designed to facilitate the study of RAVER1—the RNA binding protein hypothesized to play a pivotal role in various cellular processes, including RNA splicing, transport, and translation. These knockout cell lines are engineered through the CRISPR-Cas9 gene-editing technology, effectively inactivating the RAVER1 gene to provide researchers with valuable models to investigate the gene's functions and its implications in human disease.
The primary function of RAVER1 Gene Knockout Cell Lines lies in their ability to allow for the elucidation of molecular pathways influenced by RAVER1 absence, thereby shedding light on the biological mechanisms at play in cellular responses to stress, division, and differentiation. By employing these knockout lines, researchers can rigorously assess how the loss of RAVER1 impacts various cellular activities and contributes to disease states, such as cancer or neurodegenerative disorders.
From a scientific perspective, the importance of RAVER1 Gene Knockout Cell Lines extends into both fundamental research and clinical applications. In a research setting, these models provide an invaluable tool for exploring RNA metabolism and gene regulatory networks, potentially leading to the identification of novel therapeutic targets. Clinicians may leverage insights gained from these studies to guide patient-specific treatments or diagnostics related to RAVER1-associated conditions.
One of the distinct advantages of our RAVER1 Gene Knockout Cell Lines over alternatives is their high specificity and efficiency, made possible by precise genome editing capabilities. Unlike traditional knockout methods that may yield incomplete inactivation, our cell lines exhibit a complete absence of RAVER1 expression, ensuring reliable experimental outcomes. Moreover, our comprehensive validation processes guarantee that the cell lines maintain consistent genetic profiles, thus enhancing research reproducibility.
For researchers and clinicians alike, the RAVER1 Gene Knockout Cell Lines represent a critical asset in advancing our understanding of gene function and its relation to health and disease. The access to these high-quality cell lines not only accelerates the pace of discovery but also fosters a deeper understanding of complex biological systems.
At our company, we pride ourselves on our expertise in genetic engineering and the production of reliable biological research tools. Our commitment to quality and innovation ensures that scientists across various disciplines can trust our product offerings, including the RAVER1 Gene Knockout Cell Lines, as vital components in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.